|
2024
|
Invention
|
Polymorphic forms of the compounds targeting mutant of p53 and uses thereof. Provided herein are ... |
|
|
Invention
|
Tricyclic compounds.
Disclosed are tricyclic compounds as bromodomain and extra-terminal (BET) i... |
|
|
Invention
|
Use of compound a for treating a cancer. Provided herein is a method or a use for treating a canc... |
|
|
Invention
|
A pharmaceutical combination and use thereof. Provided herein is a pharmaceutical combination and... |
|
|
Invention
|
K-ras inhibitors and use thereof. The invention relates to compounds that inhibit the activity of... |
|
|
Invention
|
Heterocyclic derivatives useful as shp2 inhibitors. This invention provides a compound of formula... |
|
|
Invention
|
Heterocyclic derivatives useful as shp2 inhibitors.
This invention provides a compound of formul... |
|
2023
|
Invention
|
Compounds targeting mutant of p53. The present invention provides compounds of formula (I) which ... |
|
|
Invention
|
Fused cyclic compounds and use thereof. The invention relates to fused cyclic compounds, a compos... |
|
|
Invention
|
K-ras mutant protein inhibitors. The invention provides K-Ras mutant protein inhibitors of formul... |
|
|
Invention
|
Compounds targeting y220c mutant of p53. The present invention discloses compounds of formula (I)... |
|
|
Invention
|
Solid forms of compound i or salts thereof. The present invention relates to novel forms of Compo... |
|
|
Invention
|
Vaccine adjuvants and uses thereof. Provided is a vaccine adjuvant containing a STING agonist and... |
|
|
Invention
|
K-ras mutant protein inhibitors. Provided herein are KRAS mutant protein inhibitors of formula (I... |
|
|
Invention
|
K-ras mutant protein inhibitors. The invention relates to KRAS mutant protein inhibitors of formu... |
|
|
Invention
|
Polymorphic forms of glutamine antagonist and uses thereof. Provided herein are new polymorph for... |
|
|
Invention
|
Pharmaceutical combination and use thereof. Provided herein is a pharmaceutical combination compr... |
|
2022
|
Invention
|
Compound-linker constructs comprising novel compounds useful as sting agonists and uses thereof. ... |
|
|
Invention
|
Polycyclic fused ring derivatives and use thereof.
Provided are K-Ras mutant protein inhibitors ... |
|
|
Invention
|
Polycyclic fused ring derivatives and use thereof. Provided are K-Ras mutant protein inhibitors o... |
|
|
Invention
|
1, 4-oxazepane derivatives and uses thereof.
A Compound of formula (I) or (II), a stereoisomer t... |
|
|
Invention
|
N-cyclopropylpyrido [4, 3-d] pyrimidin-4-amine derivatives and uses thereof.
Provided herein is ... |
|
|
Invention
|
Pyridine fused pyrimidine derivatives and use thereof. The invention relates to a compound of For... |
|
|
Invention
|
Bicyclic derivatives and use thereof. A compound of Formula (I), (II) or (III), stereoisomer ther... |
|
|
Invention
|
N-cyclopropylpyrido [4, 3-d] pyrimidin-4-amine derivatives and uses thereof. Provided herein is a... |
|
|
Invention
|
1, 4-oxazepane derivatives and uses thereof. A Compound of formula (I) or (II), a stereoisomer th... |
|
|
Invention
|
Compounds targeting mutant of p53.
Provided are compounds of formula (I) which can bind to mutan... |
|
|
Invention
|
Compounds targeting mutant of p53. Provided are compounds of formula (I) which can bind to mutant... |
|
|
Invention
|
Polymorphic forms of aurora a selective inhibitors and uses thereof.
Provided herein are salts o... |
|
|
Invention
|
Polymorphic forms of aurora a selective inhibitors and uses thereof. Provided herein are salts of... |
|
|
Invention
|
Novel forms of compound i and use thereof. The present invention relates to novel forms of Compou... |
|
|
Invention
|
Compounds targeting y220c mutant of p53. Provided are compounds of formula (I) which can bind to ... |
|
|
Invention
|
Novel compounds useful as sting agonists and uses thereof.
Compounds of general Formula I, II, I... |
|
|
Invention
|
Novel compounds useful as sting agonists and uses thereof. Compounds of general Formula I, II, II... |
|
|
Invention
|
Novel compounds useful as sting agonists and uses thereof.
Compounds of general Formula S-1, S-2... |
|
|
Invention
|
Novel compounds useful as sting agonists and uses thereof. Compounds of general Formula S-1, S-2,... |
|
|
Invention
|
Fused ring derivatives useful as kras g12d inhibitors.
The invention relates to a KRAS G12D inhi... |
|
|
Invention
|
Fused ring derivatives useful as kras g12d inhibitors. The disclosure relates to a KRAS G12D inhi... |
|
|
Invention
|
Kras g12d inhibitors. Provided are KRAS G12D inhibitors of formula (I) or formula (IV), a composi... |
|
|
Invention
|
Tricyclic derivatives useful as parp7 inhibitors.
Provided are a compound of formula (I) that in... |
|
|
Invention
|
Tricyclic derivatives useful as parp7 inhibitors. Provided are a compound of formula (I) that inh... |
|
2021
|
Invention
|
Kras g12d inhibitors.
KRAS G12D inhibitors of Formula (I), a composition containing the inhibito... |
|
|
Invention
|
Kras g12d inhibitors.
Provided are KRAS G12D inhibitors of formula (I), a composition containing... |
|
|
Invention
|
Novel glutamine analogs.
The invention relates to novel glutamine analogs, a composition contain... |
|
|
Invention
|
Kras mutant protein inhibitors. The invention relates to a KRAS mutant protein inhibitor shown as... |
|
|
Invention
|
Novel heterocyclic compounds useful as aurora a selective inhibitors.
Provided are compounds of ... |
|
2020
|
Invention
|
Binding molecule specifically for cd39 and use thereof.
Provided is a binding molecule specifica... |
